Cg Oncology Overview
Cg Oncology Target Price
Where could CGON trade next? Consensus target price: $93.
Get informed when a big investor buys or sells
+ FollowShare Price
$72.64
Average Target Price
$92.50
27.3% upside
27.3% upside2 analysts in the last 4 months
High: $100 | Low: $85
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-07 | Truist Financial | $85 | 17% upside |  |
| 2026-07-29 | H.C. WainwrightAndres Maldonado | $100 | 37.7% upside | |
| 2026-05-14 | Truist Financial | $82 | 12.9% upside | |
| 2026-05-11 | RBC Capital | $81 | 11.5% upside | |
| 2026-05-11 | Wedbush | $80 | 10.1% upside | |
| 2026-04-27 | RBC Capital | $79 | 8.8% upside | |
| 2026-03-26 | UBS | $90 | 23.9% upside | |
| 2026-02-10 | Truist Financial | $75 | 3.2% upside | |
| 2026-01-21 | RBC Capital | $73 | 0.5% upside | |
| 2026-01-16 | Piper SandlerKelsey Goodwin | $70 |  3.6% downside | |
| 2026-01-12 | Goldman Sachs | $82 | 12.9% upside | |
| 2026-01-09 | Morgan Stanley | $93 | 28% upside | |
| 2026-01-09 | Truist Financial | $66 | 9.1% downside | |
| 2026-01-08 | Morgan StanleySean Laaman | $89 | 22.5% upside | |
| 2025-12-11 | Wedbush | $70 | 3.6% downside | |
| 2025-11-24 | Truist FinancialGregory Renza | $62 | 14.6% downside | |
| 2025-11-17 | RBC Capital | $61 | 16% downside | |
| 2025-10-07 | GuggenheimBrad Canino | $90 | 23.9% upside | |
| 2025-09-17 | Morgan Stanley | $79 | 8.8% upside | |
| 2025-08-19 | Piper SandlerKelsey Goodwin | $55 | 24.3% downside | |
| 2025-03-07 | Morgan Stanley | $55 | 24.3% downside | |
| 2024-10-24 | UBSDavid Dai | $60 | 17.4% downside | |
| 2024-09-17 | H.C. WainwrightAndres Maldonado | $75 | 3.2% upside | |
| 2024-09-16 | Goldman SachsCorinne Johnson | $52 | 28.4% downside | |
| 2024-05-13 | Goldman SachsCorinne Johnson | $50 | 31.2% downside | |